- BS (Mathematics), University of Nice, France, 1983
- BS (Physics & Chemistry), University of Nice, France, 1985
- MS (Chemistry), University of Nice, France, 1986
- MS (Molecular Chemistry), University of Nice, France, 1987
- MS (Molecular Biology), Free University of Brussels, Belgium, 1990
- PhD (Biological Chemistry), Free University of Brussels, Belgium, 1996
- 1996-1998, University of California San Francisco, San Francisco.
- 1999-2001, University of Würzburg, Germany.
Education & Training
My work integrates computational, structural, molecular, and biochemical techniques using cell and in vivo mouse studies. The outcome of these investigations is revealing new and fundamental information about the Structural and Molecular Basis of GPCR regulation of Ca2+ homeostasis. This endeavor is a foundation to understand how class B and C GPCRs regulate biomolecule homeostasis pathways that are critically important to health and disease.
Calcium homeostasis is quintessential in numerous physiological processes, from bone formation to nerve transmission and cardiac contractility. The parathyroid hormone (PTH) type 1 receptor (PTH1R) is a central G protein-coupled receptor (GPCRs) regulating the maintenance of essential elements in calcium homeostasis – serum Ca2+, PTH, Vitamin D, and phosphate ions. The disorders in mechanisms regulating calcium homeostasis are associated with significant human morbidity, including bone diseases, kidney stones, and soft tissue calcification, which are very common and pose serious health threats. Current treatments have multiple caveats.
My laboratory has engineered optical systems (FRET) for studying signaling processes for the PTH1R as well as other GPCRs in real-time and live cells, and have thereby made a series of breakthrough observations that have led to new paradigms of GPCR signaling and regulation mechanisms in endosomes. We discovered that the PTH1R is one of the first GPCRs found to sustain cAMP signaling after internalization of the PTH–PTH1R complex in endosomes, a process with both physiological and disease relevance. Recently, my lab has regrouped and assembled an international consortium that applied state-of-the-art cryoelectron microscopy to reveal near-atomic 3Å resolution of the PTHR in complex with the Gs protein that was published in Science (2019).
Following the resolution of the PTHR structure, I regrouped a new team of investigators that is applying an innovative computational pipeline combining molecular dynamics (MD) simulations and elastic network model (ENM)-based methods for a comprehensive understanding of the mode of action of the PTHR. This ongoing work is revealing precision modulation of hormonal signaling responses recently published in Nature Chem Biol (2022), Science Signaling (2021), Nature Communications (2024), PNAS (2025) and addressing the key question of how to drug a difficult target such as the PTHR effectively. These results give us invaluable mechanistic insights into PTHR activation and provide a framework for the proposed studies that will permit a rational development of therapies in the kidney–bone axis in mineral diseases.
